CTRI/2019/07/020139尚未招募2 期
Phase II : Multicentre clinical study to assess the performance of the Xpert MTB/XDR Assay for INH and Second Line Resistance Detection Xpert MTB/XDR Clinical Evaluation
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Age 18 years and above
- •Symptoms suggesting pulmonary TB
- •Previously received more than 1 month of treatment for prior TB episode
- •Failing TB treatment with positive smear or culture after three months of standard treatment
- •Close contact with drug resistant TB case
- •Newly diagnosed with MDRTB within the last 30 days
- •Previously diagnosed with MDRTB and failed TB treatment with positive sputum or culture after three months of standard MDRTB treatment
排除标准
- •Participants will be excluded from the study if informed consent is not provided
研究者
相似试验
未知
2 期
A phase 2 multicenter clinical study evaluating the safety and efficacy of Nilotinib in patients with Imatinib- resistant/intolerant CML in chronic phaseChronic myelogenous leukemiaJPRN-UMIN000001927Tokyo STI Study Group50
进行中（未招募）
不适用
A multicenter phase II clinical trial assessing the efficacy of the combination of lapatinib and capecitabine in patients with non pretreated brain metastasis from HER2 positive breast cancer. - LANDSCAPEEUCTR2008-001084-10-FRFNCLCC
已完成
不适用
Phase II Multicenter Clinical Trial to evaluate the immune response generation capacity and the safety of the ALVAC-HIVVCP1452 Vaccine administered alone and in combination with the MN rpg 120 / HIV-1 vaccine in humans from Brazil, Haiti, Peru and Trinidad and Tobago.-B23 Human immunodeficiency virus [HIV] disease resulting in other conditionsHuman immunodeficiency virus [HIV] disease resulting in other conditionsB23PER-036-01FRED HUTCHINSON CANCER RESEARCH CENTER,
进行中（未招募）
不适用
A phase II, multicentre, clinical study evaluating the safety and efficacy of Treosulfan-based conditioning of allogenic transplantation of haemopoietic stem-cells in patients affected by Thalassemia Major - NDEUCTR2005-005913-40-ITOSPEDALE POLICLINICO S. MATTEO10
已完成
2 期
Multicenter Phase II study to evaluate efficacy and safety of combination therapy with trastuzumab and pertuzumab in patients with HER2-positive metastatic colorectal cancercolorectal cancerJPRN-UMIN000027887ational Cancer Center Hospital East30